Post-COVID Profile

Post-COVID Profile is a comprehensive laboratory testing panel designed to assess the body's condition after COVID-19 infection. The profile helps identify potential post-COVID complications, evaluate the function of vital organs and systems, detect signs of inflammation, blood clotting disorders, metabolic abnormalities, and determine the need for further monitoring or treatment.

Test Panel

Complete blood count and inflammatory markers

• Complete Blood Count (CBC) – evaluates blood cell composition and helps detect inflammation, anemia, and changes in the immune response.
• Erythrocyte Sedimentation Rate (ESR) – a non-specific marker of inflammation.

Urinalysis and kidney function

• Urinalysis with urine sediment examination – evaluates the urinary tract and helps identify possible kidney disorders.
• Serum Creatinine – assesses kidney filtration function.
• Urea – provides additional evaluation of kidney function and protein metabolism.

Metabolism and liver function

• Glucose – assesses carbohydrate metabolism.
• Alanine Aminotransferase (ALT) – marker of liver cell injury.
• Aspartate Aminotransferase (AST) – evaluates the condition of the liver, heart, and skeletal muscles.
• Gamma-Glutamyl Transferase (GGT) – assesses liver and biliary tract function.
• Ferritin – evaluates iron stores and serves as a marker of inflammation.

Lipid profile

• Total Cholesterol – assesses lipid metabolism.
• LDL Cholesterol – evaluates the risk of atherosclerosis.
• HDL Cholesterol – the protective cholesterol fraction associated with cardiovascular health.

Blood coagulation

• Prothrombin Index (PT, %) – evaluates the blood clotting capacity.
• Fibrinogen (Factor I) – an important marker of coagulation and inflammation.
• D-dimer – marker of blood clot formation and breakdown.

Cardiac assessment

• CK-MB (Creatine Kinase MB) – marker of heart muscle injury.

Post-infection immunity

• SARS-CoV-2 IgG antibodies (Spike and Nucleocapsid proteins), qualitative test – determines the presence of an immune response following COVID-19 infection.

Testing Method

• automated hematology analysis;
• biochemical analysis of blood and urine;
• immunoturbidimetric assays;
• coagulation testing;
• chemiluminescent immunoassay (CLIA) for the detection of SARS-CoV-2 antibodies.

Procedure

• the profile requires venous blood and urine samples;
• venous blood is collected by qualified healthcare professionals;
• a first-morning urine sample collected in a sterile container is used for urinalysis;
• after collection, the samples are processed in the laboratory for comprehensive analysis;
• blood collection takes only a few minutes and does not require hospitalization.